Immune Drug Doesn’t Help Kids with Hard-to-Treat Kidney Disorder
American Society of Nephrology (ASN)Highlights • Children with a particular kidney immune disorder that is unresponsive to standard treatments do not benefit from the immune drug rituximab. • Additional studies are needed to fully understand the disease and to develop effective therapies for hard-to-treat cases.